<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045423"><TermName>bexarotene</TermName><TermPronunciation>(bek-SAYR-uh-teen)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat skin problems caused by cutaneous T-cell lymphoma that have not gotten better after other treatment. It is also being studied in the treatment of other types of cancer. Bexarotene is a type of retinoid. Also called LGD1069 and Targretin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705445" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;bexarotene&quot;" language="en" id="_5"/><MediaLink ref="CDR0000705444" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;bexaroteno&quot;" language="es" id="_4"/><SpanishTermName>bexaroteno</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar problemas  de la piel  por causa del linfoma cutáneo de células T que no han mejorado después del tratamiento. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. El bexaroteno es un tipo de retinoide. También se llama LGD1069 y Targretin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2006-11-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000500219">Bexarotene</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
